ResearcherJilin Medical UniversityNo recent work listed
Wenhe Zhu
Matched on ORCID iD 0000-0003-2766-0060; OpenAlex author ID A5007570075. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper
Papers 4
- Dihydroartemisinin induces apoptosis and downregulates glucose metabolism in JF-305 pancreatic cancer cells. Co-author DOI 10.1039/c8ra00565f↗
- [Dihydroartemisinin inhibits proliferation of pancreatic cancer JF-305 cells by regulating expression of apoptosis related proteins and production of reactive … Last author DOI 10.19540/j.cnki.cjcmm.2017.0122↗
- Apoptosis induced by microwave radiation in pancreatic cancer JF305 cells. Co-author DOI 10.1139/cjpp-2013-0220↗
- [Inhibitory effect of microwave radiation on proliferation of human pancreatic cancer JF305 cells and its mechanism]. Co-author PMID 24459920↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shijie Lv · 3 shared papers, 2014–2018 · strength 0.21
- Paper Dihydroartemisinin induces apoptosis and downregulates glucose metabolism in JF-305 pancreatic cancer cells. DOI 10.1039/c8ra00565f↗
- Paper [Dihydroartemisinin inhibits proliferation of pancreatic cancer JF-305 cells by regulating expression of apoptosis rela… DOI 10.19540/j.cnki.cjcmm.2017.0122↗
- Paper Apoptosis induced by microwave radiation in pancreatic cancer JF305 cells. DOI 10.1139/cjpp-2013-0220↗
- Yawei Li · 2 shared papers, 2017–2018 · strength 0.16
- Paper Dihydroartemisinin induces apoptosis and downregulates glucose metabolism in JF-305 pancreatic cancer cells. DOI 10.1039/c8ra00565f↗
- Paper [Dihydroartemisinin inhibits proliferation of pancreatic cancer JF-305 cells by regulating expression of apoptosis rela… DOI 10.19540/j.cnki.cjcmm.2017.0122↗
- Huiyan Wang · 1 shared paper, 2018 · strength 0.08
- LU Shi-jie · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.